Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TreVia Digital Health is a private U.S. digital health company focused on diabetes care, particularly technology-enabled screening and care coordination for diabetic eye disease. The company provides digital diabetic retinopathy screening and a cloud-based telemedicine platform that supports remote image capture, specialist review, and rapid communication of results. Its offering is aimed at preventive screening and early detection of diabetic complications for healthcare systems, providers, payers, retail settings, government programs, and international customers. TreVia appears to operate as a commercial-stage healthcare technology company rather than a drug developer, with its core value centered on improving diabetes outcomes through telemedicine-enabled workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TreVia Digital Health.